Internal Medicine
CASE REPORTS
Rescue Therapy with Tacrolimus for a Patient with Severe Ulcerative Colitis Refractory to Combination Leukocytapheresis and High-Dose Corticosteroid Therapy
Hiroshi NakaseSakae MikamiMinoru MatsuuraSatoru UenoNorimitsu UzaSatoko InoueHiroshi KitamuraKatsuhiro KasaharaTakuya YoshinoYasuhiro TakedaTsutomu Chiba
Author information
JOURNALS OPEN ACCESS

Volume 46 (2007) Issue 11 Pages 717-720

Details
Download PDF (3794K) Contact us
Abstract

A19-year-old man complaining of severe diarrhea and hematochezia was admitted to our hospital. Endoscopic findings and laboratory data revealed that he had ulcerative colitis (UC). Despite combination therapy with high-dose corticosteroids and intensive granulocytapheresis, his condition did not improve. Therefore, we initiated tacrolimus therapy. Intravenous administration of tacrolimus with a trough level of 10 to 15 ng/ml relieved his abdominal symptoms within 1 week. The patient experienced no UC relapse 1 year after treatment with oral tacrolimus. Tacrolimus is a promising therapy for patients with UC refractory to the combination of high-dose corticosteroids and leukocytapheresis.

Information related to the author
© 2007 by The Japanese Society of Internal Medicine
Previous article Next article

Recently visited articles
feedback
Top